Genetic and Syndromic Causes of Obesity: Diagnosis and Management

Excerpt

Genetic and epigenetic factors play a vital role in the pathogenesis of obesity. Obesity affects over 650 million adults worldwide, with most attributed to polygenic factors combined with environmental influences. While monogenic and syndromic forms of obesity are rare, recognizing them is essential, as accurate diagnosis directly informs targeted treatment strategies and optimizes patient outcomes. These genetic forms of obesity typically present with severe, early-onset obesity accompanied by distinctive clinical features that differentiate them from typical polygenic obesity.

The most studied monogenic form of obesity involves the leptin-melanocortin pathway, the central regulatory mechanism for energy homeostasis and appetite control. Monogenic obesity affects approximately 1% to 5% of individuals with severe, early-onset obesity, defined as obesity that begins before age 5 in children whose body mass index (BMI) is greater than the 95th percentile for age and sex. The most common monogenic causes involve disruptions in the leptin-melanocortin pathway, including leptin deficiency, leptin receptor (LEPR) deficiency, melanocortin-4 receptor (MC4R) deficiency, and proopiomelanocortin (POMC) or proprotein convertase subtilisin/kexin type 1 (PCSK1) deficiencies. Early recognition of genetic and syndromic causes of obesity is crucial for implementing appropriate interventions, providing genetic counseling, and optimizing long-term outcomes. The development of targeted therapies, eg, setmelanotide and diazoxide choline extended-release tablets, VYKAT XR, represents significant advances in the treatment of these previously difficult-to-manage conditions.

Epidemiology of Genetic Obesity

Twin studies have estimated the heritability of obesity to be between 40% and 70%. Over 100 genetic loci contribute to typical obesity, as identified through genome-wide association studies (GWAS). However, the identified loci explain only a small fraction of the heritability, a phenomenon known as the "missing heritability" problem. Possible explanations for this missing heritability include rare variants with large effect sizes, gene-gene interactions, and epigenetic modifications not captured in traditional GWAS studies.

Obesity Epigenetics

Epigenetic modifications, eg, deoxyribonucleic acid (DNA) methylation and histone modifications, influence gene expression without altering the underlying DNA sequence. Environmental factors, eg, maternal nutrition during pregnancy, can influence these modifications. For example, maternal undernutrition during pregnancy has been linked to an increased risk of obesity in offspring through epigenetic mechanisms that affect genes involved in metabolism and appetite regulation.

Red Flags for Genetic Obesity

Clinicians should request a referral for a genetic evaluation if any of the following red flag indicators are present in patients with obesity:

1. Severe obesity onset before age 5 years

2. Hyperphagia with food-seeking behaviors

3. Obesity accompanied by developmental delays

4. Obesity with distinctive dysmorphic features

5. A family history of severe early-onset obesity

6. Obesity and endocrine abnormalities (eg, hypogonadism and growth hormone deficiency)

7. Obesity and vision problems or polydactyly

8. A failure to respond to standard weight management interventions

Genetic Obesity Pathophysiology Overview

The pathophysiology of genetic obesity primarily involves disruption of the hypothalamic leptin-melanocortin pathway, which serves as the central regulatory system for energy homeostasis. This pathway begins with leptin, an adipocyte-derived hormone that signals satiety to the hypothalamus. Please refer to the StatPearls companion resource, "Physiology, Leptin", for further information on leptin physiology. Within the hypothalamus, leptin signaling activates proopiomelanocortin (POMC) neurons, which produce α-melanocyte-stimulating hormone (α-MSH) through cleavage by proprotein convertase subtilisin/kexin type 1 (PCSK1). Melanocortin-4 receptors (MC4R) bind to α-MSH on downstream neurons, decreasing food intake and increasing energy expenditure. Disruption at any point in this pathway results in severe obesity characterized by hyperphagia, reduced satiety, and decreased energy expenditure. The severity of the phenotype often correlates with the degree of pathway disruption, with complete deficiencies producing more severe obesity than partial deficiencies (see Table 1).